<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wiki.beaconcancer.org/index.php?action=history&amp;feed=atom&amp;title=ALK</id>
	<title>ALK - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wiki.beaconcancer.org/index.php?action=history&amp;feed=atom&amp;title=ALK"/>
	<link rel="alternate" type="text/html" href="https://wiki.beaconcancer.org/index.php?title=ALK&amp;action=history"/>
	<updated>2026-10-17T11:55:10Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.39.5</generator>
	<entry>
		<id>https://wiki.beaconcancer.org/index.php?title=ALK&amp;diff=22013&amp;oldid=prev</id>
		<title>Victor at 14:24, 27 August 2024</title>
		<link rel="alternate" type="text/html" href="https://wiki.beaconcancer.org/index.php?title=ALK&amp;diff=22013&amp;oldid=prev"/>
		<updated>2024-08-27T14:24:32Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 14:24, 27 August 2024&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot;&gt;Line 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;ALK, or Anaplastic Lymphoma Kinase, is a gene that encodes a protein involved in cell growth and development. Genetic alterations in ALK, such as rearrangements and fusions, are found in various cancers, including non-small cell lung cancer, anaplastic large cell lymphoma, and some pediatric neuroblastomas. These alterations lead to the production of abnormal ALK proteins that drive uncontrolled cell proliferation and &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;tumor &lt;/del&gt;growth. Detecting ALK alterations is crucial for guiding treatment decisions, as ALK inhibitors are specifically designed to target and block the activity of these abnormal proteins. These targeted therapies have shown significant effectiveness in shrinking &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;tumors &lt;/del&gt;and improving patient outcomes. Understanding ALK&amp;#039;s role in cancer biology enables personalized treatment approaches, offering more precise and effective options for patients with ALK-positive cancers.&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;ALK, or Anaplastic Lymphoma Kinase, is a gene that encodes a protein involved in cell growth and development. Genetic alterations in ALK, such as rearrangements and fusions, are found in various cancers, including non-small cell lung cancer, anaplastic large cell lymphoma, and some pediatric neuroblastomas. These alterations lead to the production of abnormal ALK proteins that drive uncontrolled cell proliferation and &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;tumour &lt;/ins&gt;growth. Detecting ALK alterations is crucial for guiding treatment decisions, as ALK inhibitors are specifically designed to target and block the activity of these abnormal proteins. These targeted therapies have shown significant effectiveness in shrinking &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;tumours &lt;/ins&gt;and improving patient outcomes. Understanding ALK&amp;#039;s role in cancer biology enables personalized treatment approaches, offering more precise and effective options for patients with ALK-positive cancers.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Victor</name></author>
	</entry>
	<entry>
		<id>https://wiki.beaconcancer.org/index.php?title=ALK&amp;diff=18055&amp;oldid=prev</id>
		<title>Victor: Created page with &quot;ALK, or Anaplastic Lymphoma Kinase, is a gene that encodes a protein involved in cell growth and development. Genetic alterations in ALK, such as rearrangements and fusions, are found in various cancers, including non-small cell lung cancer, anaplastic large cell lymphoma, and some pediatric neuroblastomas. These alterations lead to the production of abnormal ALK proteins that drive uncontrolled cell proliferation and tumor growth. Detecting ALK alterations is crucial fo...&quot;</title>
		<link rel="alternate" type="text/html" href="https://wiki.beaconcancer.org/index.php?title=ALK&amp;diff=18055&amp;oldid=prev"/>
		<updated>2024-05-21T18:07:26Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;ALK, or Anaplastic Lymphoma Kinase, is a gene that encodes a protein involved in cell growth and development. Genetic alterations in ALK, such as rearrangements and fusions, are found in various cancers, including non-small cell lung cancer, anaplastic large cell lymphoma, and some pediatric neuroblastomas. These alterations lead to the production of abnormal ALK proteins that drive uncontrolled cell proliferation and tumor growth. Detecting ALK alterations is crucial fo...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;ALK, or Anaplastic Lymphoma Kinase, is a gene that encodes a protein involved in cell growth and development. Genetic alterations in ALK, such as rearrangements and fusions, are found in various cancers, including non-small cell lung cancer, anaplastic large cell lymphoma, and some pediatric neuroblastomas. These alterations lead to the production of abnormal ALK proteins that drive uncontrolled cell proliferation and tumor growth. Detecting ALK alterations is crucial for guiding treatment decisions, as ALK inhibitors are specifically designed to target and block the activity of these abnormal proteins. These targeted therapies have shown significant effectiveness in shrinking tumors and improving patient outcomes. Understanding ALK&amp;#039;s role in cancer biology enables personalized treatment approaches, offering more precise and effective options for patients with ALK-positive cancers.&lt;/div&gt;</summary>
		<author><name>Victor</name></author>
	</entry>
</feed>